top of page
Treating Cancer With Precision
News
Categories
Sign up
Featured Posts
Archive
Follow Us
- Oct 25, 2017
Alpha Tau Medical avvia la prima sperimentazione clinica in Italia per la cura del tumore con le rad
Alpha Tau Medical è lieta di annunciare l’avvio della sua prima sperimentazione clinica in Italia. Lo studio che sarà condotto presso l’IRST, a Meldola, valuterà la fattibilità, la sicurezza e l’efficacia della terapia Alpha DaRT per il trattamento del carcinoma a cellule squamose (SCC) della pelle (tumore della pelle). L’equipe spera che i risultati ottenuti dallo studio condotto presso l’IRST rafforzeranno ulteriormente gli incoraggianti esiti preliminari dello studio dedic
- Oct 25, 2017
Alpha Tau Medical startet klinische Studie in Italien zur Krebsbehandlung durch Alphastrahlung
Die klinische Studie am IRST in Italien wird die Sicherheit, Ausführbarkeit und Wirksamkeit von Alpha DaRT zur Behandlung von spinozellulären Karzinomen (SZK) der Haut untersuchen. Alpha Tau Medical verkündet freudig ihre erste klinische Studie in Italien. Die Studie am IRST in Meldola wird die Machbarkeit, Sicherheit und Wirksamkeit von Alpha DaRT zur Behandlung von spinozellulären Karzinomen (SZK) der Haut (Hautkrebs) untersuchen. Von den Befunden dieser Studie erhofft sich
- Oct 19, 2017
Initiating Clinical Trials in Italy
Alpha Tau Medical is now initiating its Alpha DaRT clinical trial at IRST, Italy. The great team at IRST and Prof. Yona Keisari as well as Amnon Gat are excited about this opportunity to study the efficacy of Alpha DaRT in cancer patients suffering from Squamous Cell Carcinoma (SCC) of the skin. The revolutionary radiotherapy treatment enables a highly potent and specific targeting of solid tumors. Clinical trials in Israel showed highly promising results and the team strives
bottom of page